Across TCGA pan-cancer cohorts, MIR4507 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of MIR4507’s most consistent transcriptional readouts.
The strongest signal is observed in lung adenocarcinoma (LUAD), where MIR4507 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR4507 is over-expressed in tumor, although a few such as COAD and THCA show the opposite, repressed pattern.
LUAD, COAD, and THCA are the cancer types where MIR4507 tumor–normal differential expression is most reproducible.